ADAM10 and amyloidosis: Overexpression of these mutated forms of human ADAM10 in a mouse model of AD showed an increase in amyloid plaques and reactive gliosis compared to overexpression of wild-type human ADAM10, indicating that the mutated form of ADAM10 has reduced α-secretase activity towards APP.